Find out more about David Gyorki's experience
David Gyorki's highlights
David Gyorki's selected work
Melanoma Margins Trial-Ii: A Phase Iii, Multi-Centre Randomised Controlled Trial Investiga..
Inguinal and Ilio-inguinal Lymphadenectomy in Management of Palpable Melanoma Lymph Node M..
Skin colonization with beta papilloma virus drives tissue immunity and resistance to squam..
Displaying the 2 most recent projects by David Gyorki.
Melanoma Margins Trial-Ii: A Phase Iii, Multi-Centre Randomised Controlled Trial Investigating 1cm Vs 2cm Wide Surgical Excision Margins For Ajcc Stage Ii Primary Cutaneous Melanoma (Melmart-Ii)
Primary melanomas (PM) are routinely excised with a wide margin to prevent recurrence. For patients with higher risk PM, there is debate as ..
Displaying the 57 most recent scholarly works by David Gyorki.
Inguinal and Ilio-inguinal Lymphadenectomy in Management of Palpable Melanoma Lymph Node Metastasis: A Long-Term Prospective Evaluation of Morbidity and Quality of Life.
Michael A Henderson, D Gyorki, BH Burmeister, J Ainslie, R Fisher, J Di Iulio, BM Smithers, A Hong, K Shannon, RA Scolyer, S Carruthers, BJ Coventry, S Babington, J Duprat, HJ Hoekstra, JF Thompson
Journal article | 2019 | Annals of Surgical Oncology
PURPOSE: Prospective data are lacking on long-term morbidity of inguinal lymphadenectomy including the influence of extent of surg..
Characterizing high-grade serous papillary carcinoma of tunica vaginalis
Liang G Qu, Jiasian Teh, Catherine Mitchell, David E Gyorki, Rodney J Hicks, Declan G Murphy
Journal article | 2019 | Urology Case Reports
Serous carcinomas of the testis or para-testis are extremely rare tumors of Mullerian type. We report a case of high-grade serous ..
Efficacy of immune checkpoint inhibitors (ICIs) for in-transit melanoma.
Emilia Nan Tie, Julia Elizabeth Lai-Kwon, Lumine Na, Michael Alexander Rtshiladze, James Bozzi, Tavis Read, Victoria Atkinson, George Au-Yeung, Georgina V Long, Grant A McArthur, Shahneen Kaur Sandhu, Robyn Saw, Euan Thomas Walpole, Alexander M Menzies, B Mark Smithers, David E Gyorki
Conference Proceedings | 2019 | JOURNAL OF CLINICAL ONCOLOGY
One-year (yr) recurrence-free survival (RFS) from a randomized, open label phase II study of neoadjuvant (neo) talimogene laherparepvec (T-VEC) plus surgery (surgx) versus surgx for resectable stage IIIB-IVM1a melanoma (MEL).
Reinhard Dummer, David E Gyorki, John Robert Hyngstrom, Adam C Berger, Robert Martin Conry, Lev V Demidov, Anjali Sharma, Sheryl Treichel, Mark B Faries, Merrick I Ross
Conference Proceedings | 2019 | Journal of Clinical Oncology
Prediction and monitoring of relapse in stage III melanoma using circulating tumor DNA
L Tan, S Sandhu, RJ Lee, J Li, J Callahan, S Ftouni, N Dhomen, P Middlehurst, A Wallace, J Raleigh, A Hatzimihalis, MA Henderson, M Shackleton, A Haydon, V Mar, DE Gyorki, D Oudit, MA Dawson, RJ Hicks, P Lorigan, et al.
Journal article | 2019 | Annals of Oncology
BACKGROUND: The advent of effective adjuvant therapies for patients with resected melanoma has highlighted the need to stratify pa..
Predictors of Acute Surgical Complications Following Wide Local Excision and Sentinel Lymph Node Biopsy for Melanoma - Analysis from a Prospective Clinical Trial
DE Gyorki, M Moncrieff, R Saw, A Spillane, J Thompson, H Peach, D Oudit, J Geh, P Dziewulski, E Wilson, P Matteucci, R Pritchard-Jones, R Olofsson Bagge, F Wright, N Crampton, O Cassell, N Jallali, AC Berger, J Kelly, S Hamilton, et al.
Conference Proceedings | 2019 | ANNALS OF SURGICAL ONCOLOGY
Tissue-resident memory CD8( ) T cells promote melanoma-immune equilibrium in skin
Simone L Park, Anthony Buzzai, Jai Rautela, Jyh Liang Hor, Katharina Hochheiser, Maike Effern, Nathan McBain, Teagan Wagner, Jarem Edwards, Robyn McConville, James S Wilmott, Richard A Scolyer, Thomas Tueting, Umaimainthan Palendria, David Gyorki, Scott N Mueller, Nicholas D Huntington, Sammy Bedoui, Michael Hoelzel, Laura K Mackay, et al.
Journal article | 2019 | Nature
Accumulation of CD103( ) CD8( ) T cells in a cutaneous melanoma micrometastasis
Katharina Hochheiser, Han Xian Aw Yeang, Teagan Wagner, Candani Tutuka, Andreas Behren, Jason Waithman, Christopher Angel, Paul J Neeson, Thomas Gebhardt, David E Gyorki
Journal article | 2019 | Clinical & Translational Immunology
Objective: The immune system can halt cancer progression by suppressing outgrowth of clinically occult micrometastases in a state ..
Treatment of patients with primary retroperitoneal sarcoma: predictors of outcome from an Australian specialist sarcoma centre
Hayden A Snow, Tatiana X Hitchen, Jessica Head, Alan Herschtal, Susie Bae, Sarat Chander, Julie Chu, Shona Hendry, Samuel Y Ngan, Jayesh Desai, Peter FM Choong, Michael Henderson, David E Gyorki
Journal article | 2018 | ANZ Journal of Surgery
Circulating tumour DNA analysis predicts relapse following resection in stage II and III melanoma
L Tan, SK Sandhu, R Lee, J Li, J Callahan, J Raleigh, A Hatzimihalis, P Middlehurst, M Henderson, M Shackleton, A Haydon, D Gyorki, D Oudit, RJ Hicks, P Lorigan, GA McArthur, R Marais, SQ Wong, S-J Dawson
Conference Proceedings | 2018 | ANNALS OF ONCOLOGY
1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility Study
Marc D Moncrieff, David Gyorki, Robyn Saw, Andrew J Spillane, Howard Peach, Deemesh Oudit, Jenny Geh, Peter Dziewulski, Ewan Wilson, Paolo Matteucci, Rowan Pritchard-Jones, Roger Olofsson Bagge, Frances C Wright, Nic Crampton, Oliver Cassell, Navid Jallali, Adam Berger, John Kelly, Stephen Hamilton, Amer Durrani, et al.
Journal article | 2018 | Annals of Surgical Oncology
Multiplex immunohistochemistry accurately defines the immune context of metastatic melanoma
H Halse, AJ Colebatch, P Petrone, MA Henderson, JK Mills, H Snow, JA Westwood, S Sandhu, JM Raleigh, A Behren, J Cebon, PK Darcy, MH Kershaw, GA McArthur, DE Gyorki, PJ Neeson
Journal article | 2018 | Scientific Reports
Surveillance imaging with FDG-PET/CT in the post-operative follow-up of stage 3 melanoma
J Lewin, L Sayers, D Kee, I Walpole, A Sanelli, L te Marvelde, A Herschtal, J Spillane, D Gyorki, D Speakman, V Estall, S Donahoe, M Pohl, K Pope, M Chua, S Sandhu, GA McArthur, CJ McCormack, M Henderson, RJ Hicks, et al.
Journal article | 2018 | Annals of Oncology
Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis
Peter Savas, Balaji Virassamy, Chengzhong Ye, Agus Salim, Christopher P Mintoff, Franco Caramia, Roberto Salgado, David J Byrne, Zhi L Teo, Sathana Dushyanthen, Ann Byrne, Lironne Wein, Stephen J Luen, Catherine Poliness, Sophie S Nightingale, Anita S Skandarajah, David E Gyorki, Chantel M Thornton, Paul A Beavis, Stephen B Fox, et al.
Journal article | 2018 | Nature Medicine
When is a sentinel node biopsy indicated for patients with primary melanoma? An update of the 'Australian guidelines for the management of cutaneous melanoma'
David E Gyorki, Andrew Barbour, Mark Hanikeri, Victoria Mar, Shahneen Sandhu, John F Thompson
Journal article | 2017 | Australasian Journal of Dermatology
Surgical referral coordination from a first-level hospital: a prospective case study from rural Nepal
Matthew Fleming, Caroline King, Sindhya Rajeev, Ashma Baruwal, Dan Schwarz, Ryan Schwarz, Nirajan Khadka, Sami Pande, Sumesh Khanal, Bibhav Acharya, Adia Benton, Selwyn O Rogers, Maria Panizales, David Gyorki, Heather McGee, David Shaye, Duncan Maru
Journal article | 2017 | BMC Health Services Research
Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy
Paul A Beavis, Melissa A Henderson, Lauren Giuffrida, Jane K Mills, Kevin Sek, Ryan S Cross, Alexander J Davenport, Liza B John, Sherly Mardiana, Clare Y Slaney, Ricky W Johnstone, Joseph A Trapani, John Stagg, Sherene Loi, Lev Kats, David Gyorki, Michael H Kershaw, Phillip K Darcy
Journal article | 2017 | Journal of Clinical Investigation
Circulating Tumor DNA Analysis and Functional Imaging Provide Complementary Approaches for Comprehensive Disease Monitoring in Metastatic Melanoma
Stephen Q Wong, Jeanette M Raleigh, Jason Callahan, Ismael A Vergara, Sarah Ftouni, Athena Hatzimihalis, Andrew J Colebatch, Jason Li, Timothy Semple, Kenneth Doig, Christopher Mintoff, Devbarna Sinha, Paul Yeh, Maria Joao Silva, Kathryn Alsop, Heather Thorne, David D Bowtell, David E Gyorki, Gisela Mir Arnau, Carleen Cullinane, et al.
Journal article | 2017 | JCO Precision Oncology
A community-based model of rapid autopsy in end-stage cancer patients
Kathryn Alsop, Heather Thorne, Shahneen Sandhu, Anne Hamilton, Christopher Mintoff, Elizabeth Christie, Odette Spruyt, Scott Williams, Orla McNally, Linda Mileshkin, Sumitra Ananda, Julene Hallo, Sherene Loi, Clare Scott, Peter Savas, Lisa Devereux, Patricia O'Brien, Sameera Gunawardena, Clare Hampson, Kate Strachan, et al.
Journal article | 2016 | Nature Biotechnology
Excision margins and sentinel lymph node status as prognostic factors in thick melanoma of the head and neck: A retrospective analysis
Olivia Ruskin, Alexandra Sanelli, Alan Herschtal, Angela Webb, Ben Dixon, Miklos Pohl, Simon Donahoe, John Spillane, Michael A Henderson, David E Gyorki
Journal article | 2016 | Head & Neck
CD271 Expression on Patient Melanoma Cells Is Unstable and Unlinked to Tumorigenicity
Samantha E Boyle, Clare G Fedele, Vincent Corbin, Elisha Wybacz, Pacman Szeto, Jeremy Lewin, Richard J Young, Annie Wong, Robert Fuller, John Spillane, David Speakman, Simon Donahoe, Miklos Pohl, David Gyorki, Michael A Henderson, Ricky W Johnstone, Anthony T Papenfuss, Mark Shackleton
Journal article | 2016 | Cancer Research
Sentinel node biopsy in patients with intermediate and thick melanomas - A balanced view
Robyn Saw, Christopher Allan, Andrew Barbour, Sydney Ch'ng, Brendon J Coventry, David Gyorki, Michael Henderson, Julie Howle, T Michael Hughes, Kenneth Lee, Susan Neuhaus, Christobel Saunders, Kerwin Shannon, Mark Smithers, David Speakman, John Spillane, Jonathan Stretch
Journal article | 2015 | Australian Family Physician
Post-operative survival following metastasectomy for patients receiving BRAF inhibitor therapy is associated with duration of pre-operative treatment and elective indication
Mike He, Jane Lovell, Bee Ling Ng, John Spillane, David Speakman, Michael A Henderson, Mark Shackleton, David E Gyorki
Journal article | 2015 | Journal of Surgical Oncology
Gata-3 Negatively Regulates the Tumor-Initiating Capacity of Mammary Luminal Progenitor Cells and Targets the Putative Tumor Suppressor Caspase-14
Marie-Liesse Asselin-Labat, Kate D Sutherland, Francois Vaillant, David E Gyorki, Di Wu, Sheridan Holroyd, Kelsey Breslin, Teresa Ward, Wei Shi, Mary L Bath, Siddhartha Deb, Stephen B Fox, Gordon K Smyth, Geoffrey J Lindeman, Jane E Visvader
Journal article | 2011 | Molecular and Cellular Biology
Endoscopic management of post-cholecystectomy biliary fistula.
Michael W Hii, David E Gyorki, Kentaro Sakata, Richard J Cade, Simon W Banting
Journal article | 2011 | HPB
OBJECTIVE: Bile duct injury is an uncommon but potentially serious complication in cholecystectomy. A recognized treatment for min..
Management of synchronous tumours of the oesophagus and pancreatic head: a novel approach.
DE Gyorki, NE Clarke, MW Hii, SW Banting, RJ Cade
Journal article | 2011 | The Annals of The Royal College of Surgeons of England
Synchronous tumours of the oesophagus and pancreatic head are very rare. This report describes a unique case of an adenocarcinoma ..
Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers
Elgene Lim, Francois Vaillant, Di Wu, Natasha C Forrest, Bhupinder Pal, Adam H Hart, Marie-Liesse Asselin-Labat, David E Gyorki, Teresa Ward, Audrey Partanen, Frank Feleppa, Lily I Huschtscha, Heather J Thorne, Stephen B Fox, Max Yan, Juliet D French, Melissa A Brown, Gordon K Smyth, Jane E Visvader, Geoffrey J Lindeman
Journal article | 2009 | Nature Medicine
Surgery - St Vincent'S Hospital
The Sir Peter Maccallum Department Of Oncology
Surgery - St Vincent'S Hospital
Postgraduate Diploma in Surgical Anatomy
University of Melbourne
Bachelor of Medicine & Bachelor of Surgery
University of Melbourne